1. CMU Intellectual Repository

Browsing by Author Anchalee Avihingsanon

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 5 to 24 of 26 < previous   next >
Issue DateTitleAuthor(s)
1-Jul-2020Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in ThailandPiyawat Chaivichacharn; Anchalee Avihingsanon; Weerawat Manosuthi; Sasiwimol Ubolyam; Siraprapa Tongkobpetch; Vorasuk Shotelersuk; Baralee Punyawudho
4-May-2019Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon Sook Kim; Shinichi Oka; Ploenchan Chetchotisakd; Amanda Clarke; Khuanchai Supparatpinyo; Anchalee Avihingsanon; Winai Ratanasuwan; Sasisopin Kiertiburanakul; Kiat Ruxrungtham; Sang Youn Yang; Susan Guo; Ya Pei Liu; Moupali Das; Do Tran; Damian McColl; Roberto Corales; Chris Nguyen; David Piontkowsky
1-Jun-2021Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trialIsabelle Andrieux-Meyer; Soek Siam Tan; Sombat Thanprasertsuk; Nicolas Salvadori; Caroline Menétrey; François Simon; Tim R. Cressey; Hajjah Rosaida Hj Mohd Said; Muhammad Radzi Abu Hassan; Haniza Omar; Hoi Poh Tee; Wah Kheong Chan; Suresh Kumar; Satawat Thongsawat; Kanawee Thetket; Anchalee Avihingsanon; Suparat Khemnark; Sabine Yerly; Nicole Ngo-Giang-Huong; Sasikala Siva; Alistair Swanson; Vishal Goyal; Francois Bompart; Bernard Pécoul; Shahnaz Murad
1-Jan-2022Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trialsAnchalee Avihingsanon; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Winai Ratanasuwan; Krittaecho Siripassorn; Khuanchai Supparatpinyo; Hal Martin; Hui Wang; Tin Hung Wong; Hsiu Yin Wang
1-Apr-2015Factors associated with daily tenofovir exposure in Thai subjects taking combination antiretroviral therapyStephen J. Kerr; Baralee Punyawudho; Narukjaporn Thammajaruk; Angela Colbers; Prachya Chaiyahong; Supalak Phonphithak; Vorapot Sapsirisavat; Kiat Ruxrungtham; David M. Burger; Anchalee Avihingsanon
1-Jun-2021Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell ModulationCarolyn A. Luscombe; Anchalee Avihingsanon; Khuanchai Supparatpinyo; Sivaporn Gatechompol; Win Min Han; Gary D. Ewart; Audrey S. Thomson; Michelle Miller; Stephen Becker; Robert L. Murphy
1-Jun-2015Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Baralee Punyawudho; Thitima Pengsuparp
24-May-2019Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; David M. Burger; Sean Emery; Baralee Punyawudho
1-Apr-2022A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S. Solomon; Sandra Wagner-Cardoso; Laura Smeaton; Leonard A. Sowah; Chanelle Wimbish; Gregory Robbins; Irena Brates; Christine Scello; Annie Son; Anchalee Avihingsanon; Benjamin Linas; Donald Anthony; Estevão Portela Nunes; Dimas A. Kliemann; Khuanchai Supparatpinyo; Cissy Kityo; Pablo Tebas; Jaclyn Ann Bennet; Jorge Santana-Bagur; Constance A. Benson; Marije Van Schalkwyk; Nelson Cheinquer; Susanna Naggie; David Wyles; Mark Sulkowski
1-Jan-2022Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patientsNoppaket Singkham; Anchalee Avihingsanon; Richard C. Brundage; Angela K. Birnbaum; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Torsak Bunupuradah; Sasisopin Kiertiburanakul; Ploenchan Chetchotisakd; Baralee Punyawudho
1-Nov-2017Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patientsKanokrat Rungtivasuwan; Anchalee Avihingsanon; Narukjaporn Thammajaruk; Siwaporn Mitruk; David M. Burger; Kiat Ruxrungtham; Chonlaphat Sukasem; Baralee Punyawudho
1-Jan-2015Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function ImpairmentTim R. Cressey; Anchalee Avihingsanon; Guttiga Halue; Prattana Leenasirimakul; Pra Ornsuda Sukrakanchana; Yardpiroon Tawon; Nirattiya Jaisieng; Gonzague Jourdain; Anthony T. Podany; Courtney V. Fletcher; Virat Klinbuayaem; Chureeratana Bowonwatanuwong
1-Mar-2017Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Kiat Ruxrungtham; Anchalee Avihingsanon
1-Nov-2015Population pharmacokinetics of tenofovir in HIV/HBV co-infected patientsBaralee Punyawudho; Narukjaporn Thammajaruk; Parawee Thongpeang; Gail Matthews; Sharon R. Lewin; David Burger; Kiat Ruxrungtham; Anchalee Avihingsanon
Dec-2022Population pharmacokinetics-pharmacogenetics of efavirenz and population pharmacokinetics of lopinavir/ritonavir in Thai HIV-infected patientsBaralee Punyawudho; Anchalee Avihingsanon; Weerawat Manosuthi; Piyawat Chaivichacharn
1-Jun-2022Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and FailureDavid C. Boettiger; Vu Thien An; Nagalingeswaran Kumarasamy; Iskandar Azwa; Tavitiya Sudjaritruk; Khanh Huu Truong; Anchalee Avihingsanon; Jeremy Ross; Azar Kariminia
1-Aug-2016Renal dysfunction during tenofovir use in a regional cohort of HIV-infected individuals in the Asia-PacificJunko Tanuma; Awachana Jiamsakul; Abhimanyu Makane; Anchalee Avihingsanon; Oon Tek Ng; Sasisopin Kiertiburanakul; Romanee Chaiwarith; Nagalingeswaran Kumarasamy; Kinh Van Nguyen; Thuy Thanh Pham; Man Po Lee; Rossana Ditangco; Tuti Parwati Merati; Jun Yong Choi; Wing Wai Wong; Adeeba Kamarulzaman; Evy Yunihastuti; Benedict Lh Sim; Winai Ratanasuwan; Pacharee Kantipong; Fujie Zhang; Mahiran Mustafa; Vonthanak Saphonn; Sanjay Pujari; Annette H. Sohn; C. V. Mean; V. Saphonn; K. Vohith; F. J. Zhang; H. X. Zhao; N. Han; P. C.K. Li; W. Lam; Y. T. Chan; K. H. Wong; S. Saghayam; C. Ezhilarasi; K. Joshi; D. N. Wirawan; F. Yuliana; D. Imran; A. Widhani; S. Oka; T. Nishijima; S. Na; J. M. Kim; Y. M. Gani; R. David; S. F.Syed Omar; S. Ponnampalavanar; I. Azwa; N. Huda; L. Y. Ong; E. Uy; R. Bantique; W. W. Ku; P. C. Wu; P. L. Lim; L. S. Lee; P. S. Ohnmar; P. Phanuphak; K. Ruxrungtham; P. Chusut; S. Sirivichayakul; S. Sungkanuparph; L. Chumla; N. Sanmeema; R. Chaiwarith; T. Sirisanthana; W. Kotarathititum; J. Praparattanapan; P. Kantipong; P. Kambua; R. Sriondee; V. H. Bui; T. T. Cao; D. D. Cuong; H. L. Ha; N. Durier; B. Petersen; T. Singtoroj; D. A. Cooper; M. G. Law; D. C. Boettiger
1-Jun-2020Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysisDavid C. Boettiger; Anthony T. Newall; Pairoj Chattranukulchai; Romanee Chaiwarith; Suwimon Khusuwan; Anchalee Avihingsanon; Andrew Phillips; Eran Bendavid; Matthew G. Law; James G. Kahn; Jeremy Ross; Sergio Bautista-Arredondo; Sasisopin Kiertiburanakul
1-Nov-2019Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority TrialCissy Kityo; Debbie Hagins; Ellen Koenig; Anchalee Avihingsanon; Ploenchan Chetchotisakd; Khuanchai Supparatpinyo; Natalya Gankina; Vadim Pokrovsky; Evgeny Voronin; Jeffrey L. Stephens; Edwin Dejesus; Hui Wang; Rima K. Acosta; Huyen Cao; Erin Quirk; Hal Martin; Tariro Makadzange
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
Showing results 5 to 24 of 26 < previous   next >